Gene A, upregulated by mutant KRAS, is a potential therapeutic target for lung cancer

被引：0
作者：
Kawabe, Nozomi [1 ]
Muraki, Nao [1 ]
Tanaka, Ichidai [2 ]
Sunaga, Noriaki [3 ]
Sato, Mitsuo [1 ]
机构：
[1] Nagoya Univ, Dept Integrated Hlth Sci, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi, Japan
[3] Gunma Univ, Grad Sch Med, Dept Resp Med, Maebashi, Gumma, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-3031
引用
收藏
页码：1547 / 1547
页数：1
相关论文
共 50 条
  • [21] An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer
    Wang, Haiyun
    Lv, Qi
    Xu, Yue
    Cai, Zhaoqing
    Zheng, Jie
    Cheng, Xiaojie
    Dai, Yao
    Janne, Pasi A.
    Ambrogio, Chiara
    Koehler, Jens
    [J]. EBIOMEDICINE, 2019, 49 : 106 - 117
  • [22] Wnt signaling as potential therapeutic target in lung cancer
    Yang, Jiali
    Chen, Juan
    He, Jinxi
    Li, Jing
    Shi, Juan
    Cho, William C.
    Liu, Xiaoming
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (08) : 999 - 1015
  • [23] CD 146 a Potential Therapeutic Target for Lung Cancer
    Olajuyin, A.
    Olajuyin, A.
    Xingru, Z.
    Fagyuan, Q.
    Zhiti, W.
    Yasi, X.
    Zhang, X.
    Yaping, Z.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S658 - S659
  • [24] Metabolic rewiring in mutant Kras lung cancer
    Kerr, Emma M.
    Martins, Carla P.
    [J]. FEBS JOURNAL, 2018, 285 (01) : 28 - 41
  • [25] Targeting MEK in KRAS mutant lung cancer
    Jaenne, Pasi A.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [26] KRAS: A Promising Therapeutic Target for Cancer Treatment
    Wu, Hai-Zhou
    Xiao, Jia-Qi
    Xiao, Song-Shu
    Cheng, Yan
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (23) : 2081 - 2097
  • [27] Therapeutic microRNA agaisnt KRAS mutant colorectal cancer
    Hiraki, Masayuki
    Nishimura, Junichi
    Uemura, Mamoru
    Hata, Taishi
    Takemasa, Ichiro
    Mizushima, Tsunekazu
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [28] Targeting metabolic peculiarities: a potentially novel therapeutic approach for KRAS-mutant lung cancer?
    Abdel-Rahman, Omar
    [J]. JOURNAL OF THORACIC DISEASE, 2016, 8 (08) : E794 - E795
  • [29] KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions
    Karimi, Nastaran
    Moghaddam, Seyed Javad
    [J]. CELLS, 2023, 12 (05)
  • [30] Mucin 5ac as a potential therapeutic target for KRAS-driven lung adenocarcinoma
    Torrez, Walter V. Velasco
    Deng, Shanshan
    Ramos-Castaneda, Marco A.
    Del Aguila-Soto, Segundo W.
    Moghaddam, Seyed
    [J]. CANCER RESEARCH, 2020, 80 (16)
12345